Tag: Biosimilars

Biocon Biologics: Fully Owned Subsidiary – $5.5 Billion Deal

December 6, 2025

Biocon Biologics: Fully Owned Subsidiary – $5.5 Billion Deal

Mark Cuban’s Healthcare Disruptions: Plans & Vision

November 21, 2025

Mark Cuban’s Healthcare Disruptions: Plans & Vision

STAT+: FDA Biosimilar Pathway, Trump Drug Costs

October 30, 2025

STAT+: FDA Biosimilar Pathway, Trump Drug Costs

Dulaglutide Biosimilar HbA1c Reduction T2DM Efficacy

August 22, 2025

Dulaglutide Biosimilar HbA1c Reduction T2DM Efficacy

Web Analytics